The International Community-Acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: Rationale, design and description of study cohorts and patients

BMJ Open

Volumn 2, Issue 3, 2012, Pages

  Myint, Phyo Kyaw ^a   Kwok, Chun Shing ^a   Majumdar, Sumit R ^b   Eurich, Dean T ^b   Clark, Allan B ^a   España, Pedro P ^c   Man, Shin Yan ^d   Huang, David T ^e   Yealy, Donald M ^e   Angus, Derek C ^e   Capelastegui, Alberto ^c   Rainer, Timothy H ^d   Marrie, Thomas J ^f   Fine, Michael J ^e   Loke, Yoon K ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c HOSPITAL DE GALDAKAO   (Spain)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HONG KONG; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MORTALITY; MULTICENTER STUDY; PHYSICAL EXAMINATION; PNEUMONIA SEVERITY INDEX; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPAIN; STUDY DESIGN; UNITED STATES;

EID: 84863688763     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001030     Document Type: Article

References (40)

1. Jokinen C, Heiskanen L, Junvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol 1993;137:977-88. (Pubitemid 23191065)
2. Woodhead M. Community-acquired pneumonia: severity of illness evaluation. Infect Dis Clin North Am 2004;18:791-807. (Pubitemid 39536009)
3. World Health Organization. Who Statistical Information System (WHOSIS). WHO Mortality Database. 2005. http://www.who.int/healthinfo/morttables/en/ (accessed 11 May 2012).
4. US Department of Health and Human Services. Centers for disease Control and Prevention. National Center for Health Statistics. Charbook on Trends in the Health of Americans, 2005. DHHS publication No. 2005-1232. Hyattsville, MD: National Center for Health Statistics, 2005.
5. Colice GL, Morley MA, Asche C, et al. Treatment costs of community-acquired pneumonia in an employed population. Chest 2004;125:2140-5. (Pubitemid 38788182)
6. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J 1997;10:1530-4. (Pubitemid 27311067)
7. Adams HG, Jordan C. Infections in the alcoholic. Med Clin North Am 1984;68:179-200. (Pubitemid 14179089)
8. Ioachimescu OC, Ioachimescu AG, Iannini PB. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumonia: a 5-year experience. Int J Antimicrob Agents 2004;24:485-90. (Pubitemid 39425162)
9. Lamy O, Van Melle G, Cornuz J, et al. Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia. Eur J Intern Med 2004;15:28-34. (Pubitemid 38453039)
10. Lave JR, Lin CC, Hughes-Cromick P, et al. The cost of treating patients with community-acquired pneumonia. Sem Respir Crit Care Med 1999;20:189-98.
11. British Thoracic Society Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001;56(Suppl 4):IV1-64.
12. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 1991;115:428-36.
13. Neill AM, Martin IR, Weir R, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996;51:1010-16. (Pubitemid 26360177)
14. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50. (Pubitemid 27044625)
15. Lim WS, wan der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82.
16. Espana PP, Capelastegui A, Gorordo I, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 2006;174:1249-56. (Pubitemid 44924826)
17. Escobar GJ, Fireman BH, Palen TE, et al. Risk adjusting community-acquired pneumonia hospital outcomes using automated databases. Am J Manag Care 2008;14:158-66. (Pubitemid 351367359)
18. Charles PG, Wolfe R, Whiteby M, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneuomia. Clin Infect Dis 2008;47:375-84. (Pubitemid 352009359)
19. Rello J, Rodriguez A, Lisboa T, et al. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Crit Care Med 2009;37:456-62.
20. Singanayagam A, Chalmers JD, Hill AT. Severity assessment in community-acquired pneumonia: a review. QJM 2009;6:379-88.
21. Bont J, Hak E, Hoes AW, et al. Predicting death in elderly patients with community-acquired pneumonia: a prospective validation study reevaluating the CRB65 severity assessment tool. Arch Intern Med 2008;168:1465-8. (Pubitemid 352008428)
22. Shindo Y, Sato S, Maruyama E, et al. Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology 2008;13:731-5. (Pubitemid 351977599)
23. Buising KL, Thursky KA, Black JF, et al. Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool. Emerg Med Australas 2007;19:418-26. (Pubitemid 47547572)
24. Myint PK, Musonda P, Sankaran P, et al. Confusion, urea, respiratory rate and shock index or adjusted shock index (CURSI and CURASI) criteria predict mortality in community-acquired pneumonia. Eur J Intern Med 2010;21:429-33.
25. Myint PK, Sankaran P, Musonda P, et al. Performance of CURB-65 and CURB-age in community-acquired pneumonia. Int J Clin Pract 2009;63:1345-50.
26. Man SY, Lee N, Ip M, et al. Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 2007;62:348-53. (Pubitemid 46580578)
27. Capelastegui A, Espana PP, Quintana JM, et al. Validation of a predictive rule for the management of community acquired pneumonia. Eur Respir J 2006;27:151-7. (Pubitemid 43092679)
28. Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007;167:1655-63. (Pubitemid 47280347)
29. Majumdar SR, McAlister FA, Eurich DT, et al. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006;333:999.
30. Yealy DM, Auble TE, Stone RA, et al. Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med 2005;143:881-94. (Pubitemid 46205946)
31. Loke YK, Kwok CS, Niruban A, et al. Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax 2010;65:884-90.
32. Chalmers JD, Singanayagam A, Akram AR, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and metaanalysis. Thorax 2010;65:878-83.
33. Buising KL, Thursky KA, Black JF, et al. A prospective comparison of severity scores for identifying patients with severe community pneumonia: reconsidering what is meant by severe pneumonia. Thorax 2006;61:419-24. (Pubitemid 43723326)
34. Nathwani D, Morgan M, Masterton RG, et al. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008;61:976-94. (Pubitemid 351545546)
35. Aliberti S, Ramirez J, Cosentini R, et al. Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia. Respir Med 2011;105:1732-8.
36. Myint PK, Kamath AV, Vowler SL, et al. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing 2006;35:286-91.
37. Viasus D, Garcia-Vidal C, Castellote J, et al. Community-acquired pneumonia in patient with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine (Baltimore) 2011;90:110-18.
38. Brandão-Neto RA, Goulart AC, Santana AN, et al. The role of pneumonia scores in the emergency room in patients infected by 2009 H1N1 infection. Eur J Emerg Med 2012;19:200-2.
39. Dwyer R, Hedlund J, Darenberg J, et al. Predictors of pneumonia severity in HIV-infected adults admitted to an Urban public hospital. Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia. Scand J Infect Dis 2011;43:448-55.
40. Viasus D, Garcia-Vidal C, Cruzado JM, et al. Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease. Nephrol Dial Transplant 2011;26:2899-906.